Surrozen Initiates Dosing in Phase 1 Clinical Trial of SZN-043 for Severe Alcoholic Hepatitis
13 juin 2022 08h00 HE
|
Surrozen, Inc.
SZN-043 is a novel hepatocyte-specific R-spondin mimetic bispecific fusion protein targeting ASGR1First part of two-part Phase 1 trial starts in healthy volunteers SOUTH SAN FRANCISCO, Calif., June...
Turning Point of Tampa Recognizes Alcohol Awareness Month 2022
26 avr. 2022 09h00 HE
|
Turning Point of Tampa
Tampa, April 26, 2022 (GLOBE NEWSWIRE) -- Alcohol Awareness Month began in 1987 and was formerly funded through the National Council on Alcoholism and Dependence (NCADD). Each April, it will raise...
David Howell Releases 'Breaking Into Prison': How God Used a Womanizing Jailbird and Drunk to Get the Word Out
16 févr. 2022 10h23 HE
|
David Howell
HOUSTON, Feb. 16, 2022 (GLOBE NEWSWIRE) -- David Howell's new release, Breaking Into Prison, presents God's unfathomable love, grace, and kindness through the showcasing of God's glorious working...
Clearmind Medicine Partners With Clinipace to Commence Processes Towards FDA Approval
07 oct. 2021 08h00 HE
|
Clearmind Medicine
Toronto, Ontario, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
Clearmind Medicine to Host ‘Psychedelics for Alcoholism‘ Virtual Educational Event on October 20
01 oct. 2021 08h00 HE
|
Clearmind Medicine
TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery and...
See two people find true love and devotion in ‘Live for Me’
18 févr. 2021 00h00 HE
|
Archway Publishing
MASON, Ohio, Feb. 18, 2021 (GLOBE NEWSWIRE) -- In Emma Thomas’ new romance novel, “Live for Me” (published by Archway Publishing), the lives of two struggling people collide and take them on a...
Surrozen Awarded NIH Grant to Support Development of SZN-043, a Liver-Specific Regenerative Antibody, for the Treatment of Severe Alcoholic Hepatitis
15 oct. 2020 07h00 HE
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, has been awarded an NIH grant to...
New book offers a poetic inspiration for those who want to change their lives for the better
15 sept. 2020 01h12 HE
|
Balboa Press
JACKSON, Miss., Sept. 15, 2020 (GLOBE NEWSWIRE) -- With his latest literary offering, “Sometimes I Feel Like...” (published by Balboa Press), author and poet Jeffrey B. Hunter delivers another...
BioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA
28 nov. 2016 06h00 HE
|
BioCorRx
ANAHEIM, CA, Nov. 28, 2016 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions,...
Leading Addiction Treatment Center Father Martin's Ashley Opens Skip's Hall for Integrated Addiction Treatment
09 nov. 2015 10h48 HE
|
Father Martin's Ashley
HAVRE DE GRACE, MD--(Marketwired - Nov 9, 2015) -
Skip's Hall for Integrated Addiction Treatment facilitates integrated, individualized treatment designed for...